PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC11945493::ACT014164

LFCA

Evidence text

Paper-level observation

The inhibition rates of SVA by LFCA were 41.8%, 57.3%, 80.3%, 89.6%, 94.5%, and 96.1%.
textConfidence: medium

Assay observation

Activity
Antiviral
Subtype
General Antiviral
Measure
percent_inhibition
Comparator
=
Raw observation
89.6%
Normalized measurement
=89.6%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
BHK-21
Assay method
Not reported by source
Sequence
FKCRRWQWRMKKLGAPSITCVRRAFGGGSSVDGKEDLIWKLLSKAQEKFGKNKSR
Standardization
ready simple

Source publication

Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice.

Veterinary Sciences · 2025

DOI 10.3390/vetsci12030199 PMC11945493
Parent mention

Related peptide identities

PEPDIA-PLP-000726

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.